Commitment 1 CSR Report 2025
THE MICROBIOTA Mastering living organisms, from strain to finished product
Commitment 1 CSR Report 2025
Acting to advance better-supported health, grounded in science and appropriate use
Three complementary areas of expertise for a holistic approach
We develop solutions grounded in three complementary areas of expertise – the microbiota, phytonutrition and micronutrition – with high standards for quality, traceability, safety and reproducibility of effects. This approach rests on an integrated model that links research, innovation, manufacturing and distribution through pharmacies.
THE MICROBIOTA Mastering living organisms, from strain to finished product
We designed and marketed one of the first formulas containing probiotics in France, and were the first French laboratory to publish a clinical study on a probiotic solution.
Since 1990, we have been building probiotic expertise based on a dedicated R & D unit: rigorous selection of live strains( precise identification, characterisation, suitability for the clinical indication); controlled galenic design( stability, viability, strain compatibility); and manufacturing based on pharmaceutical-grade quality standards.
Our proprietary charter, Haute Qualité Microbiotique( HQM), has for many years governed our strain selection criteria and good manufacturing practices.
Our Microbiotic Innovation Laboratory is equipped with an automated sequencer for precise strain identification and a flow cytometer to assess viability, cell integrity and bacterial population.
SELECTION
Rigorously selected live strains
DESIGN
Controlled galenic form( stability, viability and strain compatibility)
QUALITY & SAFETY
Manufacturing practices and quality control ensured by HQM
16